Sánchez-Beltrán, J.; Soler DÃaz, J.; Herraiz, C.; Olivares, C.; Cerdido, S.; Cerezuela-Fuentes, P.; GarcÃa-Borrón, J.C.; Jiménez-Cervantes, C.
An MGRN1-Based Biomarker Combination Accurately Predicts Melanoma Patient Survival. Int. J. Mol. Sci. 2025, 26, 1739.
https://doi.org/10.3390/ijms26041739
AMA Style
Sánchez-Beltrán J, Soler DÃaz J, Herraiz C, Olivares C, Cerdido S, Cerezuela-Fuentes P, GarcÃa-Borrón JC, Jiménez-Cervantes C.
An MGRN1-Based Biomarker Combination Accurately Predicts Melanoma Patient Survival. International Journal of Molecular Sciences. 2025; 26(4):1739.
https://doi.org/10.3390/ijms26041739
Chicago/Turabian Style
Sánchez-Beltrán, José, Javier Soler DÃaz, Cecilia Herraiz, Conchi Olivares, Sonia Cerdido, Pablo Cerezuela-Fuentes, José Carlos GarcÃa-Borrón, and Celia Jiménez-Cervantes.
2025. "An MGRN1-Based Biomarker Combination Accurately Predicts Melanoma Patient Survival" International Journal of Molecular Sciences 26, no. 4: 1739.
https://doi.org/10.3390/ijms26041739
APA Style
Sánchez-Beltrán, J., Soler DÃaz, J., Herraiz, C., Olivares, C., Cerdido, S., Cerezuela-Fuentes, P., GarcÃa-Borrón, J. C., & Jiménez-Cervantes, C.
(2025). An MGRN1-Based Biomarker Combination Accurately Predicts Melanoma Patient Survival. International Journal of Molecular Sciences, 26(4), 1739.
https://doi.org/10.3390/ijms26041739